Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
|3||Active, not recruiting||
Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
|4||Active, not recruiting||
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease
† Indicates status has not been verified in more than two years